Blog

Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background

OmniSpirant Therapeutics

OmniSpirant are developing an inhaled gene therapy platform based on regenerative stem cell exosomes.

 

Our patent pending surface engineered and bioengineered stem cell exosomes will initially be used to develop a first in class regenerative gene therapy for Cystic Fibrosis. The mucus penetrating exosomes have transformative potential for treating many other respiratory diseases.